Thymopentin: Clinical Trials

2 trials of Thymopentin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow Thymopentin: new trials by email Literature Review of Thymopentin trials Research Report on Thymopentin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
Thymopentin - Hepatocellular Carcinoma
Phase 3UnknownFudan University2202007-02-012007-10-31
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
Thymopentin, Stavudine, Zidovudine - HIV Infections
Phase 3CompletedImmunobiology Research Institute2005-06-24

Conditions studied

Carcinoma, Hepatocellular (1)  ·  HIV Infections (1)  ·  Recurrence (1)

Sponsors

Fudan University (1)  ·  Immunobiology Research Institute (1)

Countries

China (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Jia Fan, MD (1)